logo
H5N1 bird flu virus is infectious in raw milk cheese for months, posing risk to public health, study shows

H5N1 bird flu virus is infectious in raw milk cheese for months, posing risk to public health, study shows

CNN15-03-2025

Raw cheese made with milk from dairy cattle infected with bird flu can harbor infectious virus for months and may be a risk to public health, according to a new study from researchers at Cornell University that was funded by the US Food and Drug Administration.
Raw milk cheeses are those made with milk that hasn't been heat-treated, or pasteurized, to kill germs.
Although federal law prohibits the sale of raw milk across state lines, sales of raw milk cheese are legal nationwide as long as it's aged at least 60 days before landing on store shelves. This requirement, which has been in place since 1949, is thought to cut the risk of contamination, since it allows development of natural acids and enzymes, which were believed to kill off pathogens.
The new study shows that this aging process may not inactivate the H5N1 virus, however, and it underscores the risk of consuming raw or undercooked foods during the bird flu outbreak, which continues to infect dairy cattle, poultry and a growing number of other animal species.
The same group of researchers previously found that H5N1 virus remained infectious in refrigerated raw milk for up to eight weeks.
Dr. Diego Diel, who led the study, says he thinks the virus may be so stable in milk and cheese because it's protected by the complex matrix of molecules around it.
'The protein and fat content in the cheese and milk provide a good environment for the virus to survive at refrigeration temperature,' said Diel, an associate professor of virology at Cornell.
Robert F. Kennedy Jr., secretary of the US Department of Health and Human Services, has said food doesn't pose a bird flu risk.
'The disease is not passed through food, so you cannot get it – as far as we know, you cannot get it from an egg or milk or meat from an infected animal,' Kennedy told Fox News in an interview that aired Tuesday.
But that's only partly true. Cats and other animals have been infected by raw cow's milk and raw pet food, and there have been at least three confirmed human infections in which investigators were unable to determine the source of the person's exposure to the H5N1 virus.
There have been no confirmed reports of people getting sick from eating or drinking bird-flu contaminated foods, including raw milk cheese, but dairy workers have been infected by getting splashed with raw milk in their faces or eyes.
It's still not entirely clear whether humans can be infected by eating or drinking contaminated food, Diel said, noting that his study wasn't really designed to answer that question.
'I do think it is possible. There is a risk of infection,' he said. 'It obviously depends on the dose, how much of that contaminated product is ingested.'
It may also depend on the strain of virus in the milk or cheese. Diel and his team tested the stability of the B3.13 virus, which originally infected cattle in the US in March 2024. B3.13 has caused only mild disease in people. However, a new strain, D1.1, which has been associated with some severe human cases, has also crossed into cattle, further increasing the risk.
For the study, the researchers made mini cheeses with milk they spiked with H5N1 virus. They made these cheeses at three pH levels: 6.6, 5.8 and the most acidic formula, 5.0.
The researchers then tested the cheeses over time to see whether any virus capable of infecting cells remained. They injected samples into fertilized chicken eggs, considered the gold standard test.
Levels of the virus remained high for the first seven days after the cheese was made and then dropped a bit in the cheeses produced at pH levels 6.6 and 5.8. But importantly, the virus remained infectious for the full two-month aging period, showing that it was remarkably stable in the cheese over a long period.
Those results were confirmed by some real-world examples. The researchers tested samples of raw milk cheese from a farm that had inadvertently produced them with milk from cows infected with bird flu. These findings also showed that levels of virus stayed high and remained infectious over the full two months of aging.
'Our study demonstrates that HPAI H5N1 virus exhibits remarkable stability throughout the cheese making process,' the authors wrote in their preprint study, posted ahead of peer review Friday.
However, the study suggested that making raw milk cheese more acidic may kill the virus and make the cheese safer to eat. No live virus was detected in the cheese produced at the lowest pH, 5.0. Prior studies have also shown that common pasteurization methods inactivate the virus.
Experts said the new study was consistent with tests of the stability of the virus in milk.
'We have also observed that milk can change the pH needed to inactivate the virus,' said Dr. Seema Lakdawala, an associate professor of microbiology and immunology at Emory University, who has been studying the transmission of H5N1.
'We and others have repeatedly observed that milk will prevent the degradation of the virus on surfaces, and it increases the pH stability, such that a much lower pH than normal is needed to inactivate the virus,' said Lakdawala, who was not involved in the new study.
The FDA posted the findings of the study Friday along with preliminary results from its own ongoing sampling study of raw cheese.
The FDA sampling study, which was announced in December, has tested 110 cheese samples taken from store shelves across the country. So far, 96 of those samples were negative by polymerase chain reaction testing, or PCR, which detects live virus as well as inactive viral particles, indicating that those cheeses probably weren't made with contaminated milk. The results from the remaining 14 samples are pending, the agency said.
'The FDA is continuing to work with Federal and state partners to address the ongoing outbreak of HPAI A (H5N1) in dairy cattle. The FDA has sampled a total of 464 pasteurized dairy products, including milk cheese butter and ice cream, all were negative for viable H5N1. In addition, multiple research studies have confirmed that pasteurization inactivates the virus,' the statement said.
Still, experts say the study is a good reminder of the importance of surveillance – and of not consuming raw milk products.
'This is another reason we should push to ensure there is no bird flu in milk products and only consume pasteurized dairy products,' Lakdawala said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Study Reveals Malaria Parasite's Secrets
Study Reveals Malaria Parasite's Secrets

Medscape

time2 hours ago

  • Medscape

Study Reveals Malaria Parasite's Secrets

Malaria parasites can hide in people's bodies for years or even decades without causing symptoms by shutting down the genes that make them visible to the immune system, a new report found. This discovery explains how people can remain infected years after developing malaria and spread the disease through mosquitos that bite them, said Kirk W. Deitsch, PhD, professor with the Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York City, and co-author of a study published in Nature Microbiology . 'What's probably happening in a place like Africa, where there's a lot of malaria transmission, is that people we thought didn't have malaria actually had these invisible parasites at really low levels in their system,' Deitsch told Medscape Medical News . The implications for elimination campaigns are significant. Currently, 'when we try to do a malaria elimination campaign, [we] treat the kids, the ones who are sick,' he said. The study suggests 'that we need to treat all asymptomatic people, the adults, because they're carrying these cryptic parasites that nobody knew about before.' Sticky Proteins and Spleen Avoidance The researchers sought to better understand how malaria persists in the body. 'There were these weird cases where a person who grew up in, let's say, Africa, had malaria several times, were no longer infected, and moved to the States. They lived in the States for a decade, maybe 12 or 13 years, and then they give blood for a transfusion, and the recipient of the transfusion gets really bad malaria,' Deitsch said. 'So clearly, those parasites have been hiding in this person for more than a decade, and nobody knew why. How are they hiding? Where are they?' Study authors focused on the var gene, which expresses an adhesive surface protein on the infected red blood cells in malaria. The protein is 'sticky,' allowing infected cells to attach to blood vessel walls and avoid being filtered out by the spleen, Deitsch said. But the parasite pays a price because the immune system can detect the sticky protein. Previous methods of analyzing the genetics of malaria looked at millions of parasites together. 'If you want to know which gene is being turned on in that population, you take all those parasites, you extract all the RNA from the population, and you look at which gene is turned on,' Deitsch explained. For the new study, researchers analyzed the malaria parasite at the single-cell level. 'We isolated single parasites and then looked at which gene is being expressed by just that individual parasite,' he said. 'We found there was always a group of parasites that had turned off the entire [ var ] gene family and were expressing no genes at all.' As a result, the red blood cells didn't produce the surface proteins, allowing them to be 'invisible' and evade the immune system. Like a Criminal The parasites don't turn invisible right away, Deitsch said. Instead, they constantly switch to different sticky proteins, like a criminal changing disguises, as the immune system swings into action. 'As soon as your antibody titer begins to rise, they just switch to a different adhesive protein.' 'The parasite only has so many copies of this adhesive protein that they can put out to the surface over their lifetime. So they run out of genes after about a year and a half or so.' Scientists used to think this meant the infection would be cleared. 'Everybody always assumed that once the parasite runs out of these genes, that the infection is over. You clear the infection, and then you're okay.' Deitsch used the metaphor of a criminal who has a closet full of 50-60 disguises. 'When you get to the last one, then you've run out, and the cops have figured out all your previous disguises. At the back of the closet, there's an invisibility cloak. They can put that on, and then the cops can't see you at all.' These invisible parasites exist at very low levels. 'Those parasites don't go to very high levels because your spleen is continuously filtering them,' Deitsch explained. 'But what they're able to do is maintain this low level of infection for a long time.' The only sign of continued infection may be a slightly enlarged spleen 'because the spleen is continuously clearing a lot of these invisible parasites by filtration,' Deitsch noted. Changes in Malaria Prevention Strategy? The findings suggest that anti-malaria efforts should treat entire populations with anti-malaria drugs, even healthy people, Deitsch said. And drugs could be developed to make the hidden parasites become visible to the immune system. However, neither strategy is simple, he said. What's next? 'We're going to continue working on the molecular mechanisms that mediate this process [and explore] how the parasites control their chromosomes and their genes to go into this silent, invisible state and then switch back out into a different state,' Deitsch said. Researchers are also studying basic questions about how parasites coordinate their disguise changes. 'There are literally trillions of parasites in the circulation of a sick individual, and they seem to coordinate switching their disguise,' Deitsch said. 'They all know to go to the same next disguise.' Outside Experts Weigh In Karine Le Roch, PhD, MS, director of the Center for Infectious Disease and Vector Research, University of California, Riverside, who was not involved with the paper, told Medscape Medical News that it's 'a rigorous, innovative, and impactful study that advances a long-standing question in malaria biology.' The report 'addresses a major paradox in malaria biology and offers a compelling explanation for asymptomatic chronic infections, which have long been poorly understood,' she said. Anna Bachmann, PhD, a research group leader at the Bernhard Nocht Institute for Tropical Medicine in Hamburg, Germany, also praised the study. Bachmann, who didn't work on the paper, said it suggests 'that P falciparum may possess even more sophisticated strategies to maintain long-term infections than previously understood.' She added that the findings have implications regarding whether migrants need more extensive screening and treatment for acute and chronic infections. 'Many parasitic infections in refugees from sub-Saharan Africa have been found to be clinically almost silent, leading to the recommendation that screening practices need to be improved, particularly with respect to parasitic infections,' she said. 'This is primarily to improve the health of migrants, but it could also become relevant in the context of a potential reintroduction of malaria in nonendemic regions as currently being observed in parts of the United States and southern Europe.' The National Institutes of Health supported Deitsch and another author via grants. Deitsch is a Stavros S. Niarchos Scholar and recipient of a William Randolph Hearst Endowed Faculty Fellowship Grant, and the William Randolph Hearst Foundation supported his institution. Another author received support from the Swiss National Science Foundation. The other authors had no disclosures.

Simple tool could detect Parkinson's disease early — it was 96% accurate in experiments
Simple tool could detect Parkinson's disease early — it was 96% accurate in experiments

New York Post

time12 hours ago

  • New York Post

Simple tool could detect Parkinson's disease early — it was 96% accurate in experiments

This pen truly is mightier than the sword. A team of researchers at UCLA has developed a high-tech diagnostic pen that can detect signs of Parkinson's disease with over 96% accuracy, offering a low-cost way to identify the neurodegenerative disorder far earlier than now. A pilot study in the journal Nature Chemical Engineering unveiled the device, which looks much like a regular pen. 3 A patient with PD using the diagnostic pen for a writing task. Nature Chemical Engineering It's able pick up on subtle motor dysfunctions before they're visible to the naked eye, all by analyzing how people write. So, how does this futuristic fountain pen work? The tip is made of a flexible silicone material infused with magnetic particles, and it writes using a special ferrofluid ink that contains nanomagnets. As someone writes, pressure from the hand deforms the tip, causing changes in magnetic fields that produce electrical signals — like a Morse code of motor function. Those signals are then analyzed to detect the difference between healthy and Parkinson's-affected motor patterns. In tests with 16 participants — including 3 with Parkinson's — the system nailed the diagnosis with 96.22% accuracy. Even more impressive? The pen worked whether people wrote on paper or in the air, meaning it doesn't even require a surface. 3 Nature Chemical Engineering Today, Parkinson's is largely diagnosed based on observations, which are subjective, or by biomarker-based imaging, which can be expensive. This diagnostic pen is portable, inexpensive and doesn't rely on a neurologist to interpret results, making it a promising option for remote screenings, home use or even telehealth checkups. 'Our development of the diagnostic pen represents a low-cost, widely disseminable and reliable technology with the potential to improve PD diagnostics across large populations and resource-limited areas,' the researchers wrote. With further validation in a larger population, the device could be used not just for early diagnosis, but for ongoing symptom tracking and personalized treatment monitoring. 3 Today, Parkinson's is largely diagnosed based on observations, which are subjective, or by biomarker-based imaging, which can be expensive. highwaystarz – This is just the latest innovation aimed at tackling Parkinson's disease, which affects more than 10 million people worldwide and has no known cure. A recent study found that psilocybin — the psychedelic compound that gave 'magic mushrooms' their trippy reputation in the 1960s — showed serious promise for improving mood and motor function in people with Parkinson's disease. Tavapadon — a new drug that mimics dopamine by targeting certain receptors — has also shown promise in clinical trials by reducing motor fluctuations and maintaining symptom control with fewer side effects than traditional therapies. Produodopa — a continuous infusion therapy first administered in the UK — was approved by the US Food and Drug Administration last fall. Innovative approaches targeting the psychological aspects of the disease have been successful as well — with tandem cycling proving to be especially popular. Some New Yorkers even find relief by playing pingpong.

Fusarium Graminearum: The Fungus Allegedly Smuggled by Chinese Researchers—and Its Risks
Fusarium Graminearum: The Fungus Allegedly Smuggled by Chinese Researchers—and Its Risks

Epoch Times

timea day ago

  • Epoch Times

Fusarium Graminearum: The Fungus Allegedly Smuggled by Chinese Researchers—and Its Risks

A fungus called Fusarium graminearum has made headlines after two Chinese researchers were charged by the FBI for allegedly smuggling it into the United States as a potential agroterrorism agent. But what exactly is this fungus—and what risks does it pose to U.S. agriculture and public health? A Common Cause of Crop Disease F. graminearum is a concerning fungus, as it can contribute to billions of dollars in agricultural losses, Gary Bergstrom, professor emeritus at Cornell University specializing in plant pathology, told The Epoch Times.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store